Fluofarma is a leading company in High Content Screening (HCS) providing services to improve the drug discovery potential of its clients.
Fluofarma combines unparalleled know how in cell biology, assay development, cutting edge High Content Screening technologies and exclusive data mining capabilities to support drug discovery programs.
Fluofarma has built a deep knowledge in numerous fields such as oncology, neurobiology, drug toxicity, cardiology and cosmetics. However Fluofarma’s technologies can be applied to all fields of drug discovery.
The Fluofarma divisions provide the most complete High Content Screening service offer on the market.
■ Development of new cell-based assay
■ Customization of cell-based assay
■ Miniaturization of cell-based assay
■ Mechanism of Action studies
Portfolio of over 600 cell-based assays
■ By cellular fonction
■ By domains
■ Custom development of software
applications
■ Custom design of algorithms
■ Data analysis
Over 40 major pharmaceutical and biotechnology companies worldwide have already used Fluofarma services to evaluate the effects of their compounds.